LYCOS RETRIEVER
Israel: Countries
built 315 days ago
A wave of Jewish immigration beginning in 1989, predominantly from the countries of the former U.S.S.R., brought nearly a million new citizens to Israel. These new immigrants, many of them highly educated, now constitute some 13% of Israel's 6.7 million inhabitants. Their successful absorption into Israeli society and its labor force forms a remarkable chapter in Israeli history. The skills brought by the new immigrants and their added demand as consumers gave the Israeli economy a strong upward push and in the 1990s, they played a key role in the ongoing development of Israel's high-tech sector.
Source:
Egypt began peace initiatives with Israel in late 1977, when Egyptian President Sadat visited Jerusalem. A year later, with the help of U.S. President Jimmy Carter, terms of peace between Egypt and Israel were negotiated at Camp David, Md. (see Camp David accords). A formal treaty, signed on Mar. 26, 1979, in Washington, D.C., granted full recognition of Israel by Egypt, opened trade relations between the two countries, returned the Sinai to Egyptian control (completed in 1982), and limited Egyptian military buildup in the Sinai.
Source:
Mr. Bernstein said Israel has tremendous expertise in four areas: security, biotechnology, water-related services and agro-tech. The country already provides agro-tech knowledge to Central American nations and the Dominican Republic. One goal of the forum, Mr. Bernstein said, is to unite business people on a quarterly basis and have networking events.
Source:
Luzzatto & Luzzatto, one of the largest patent law firms in Israel, provides intellectual property services to clients throughout the world. With dynamic departments in all relevant technological fields, the firm delivers high-quality services across industries and issues. The firm's involvement in major patent and trademark cases puts it at the forefront of the IP field in the country.
Source:
It was through an existing relationship to Professor Zvia Agur, founder of Optimata, that Dr. Paolo Baroldi, the VP of corporate drug development at Chiesi Farmaceutici, Italy came to Israel. By the time the delegation approached him in his home country, he had already heard wonderful things about Israeli biotech through Agur.
Source: